Menu

#Jiangsuhengruipharmaceuta

1 post

Feed
1 of 1 post
Bristol-Myers Inks Up to $15 Billion Licensing Deal With Hengrui
📰
0

Bristol-Myers Inks Up to $15 Billion Licensing Deal With Hengrui

Bloomberg.com·Manuel Baigorri, Amber Tong·21 days ago
#Czsoh7eh

Bristol-Myers Squibb Co. inked a collaboration and licensing deal with Jiangsu Hengrui Pharmaceuticals Co. that could be valued at as much as $15.2 billion, as the US drugmaker seeks to leverage China’s efficiency in early development.

15s
Read More